Log in
Congenital malformations

Fetal alcohol spectrum disorder

Fetal alcohol spectrum disorder is a group of permanent conditions caused by prenatal alcohol exposure, ranging from full fetal alcohol syndrome to subtler neurodevelopmental deficits. It affects children of mothers who drank alcohol during pregnancy, with no established safe amount or safe trimester. The single most testable fact is the triad of full FAS: growth deficiency, characteristic facial anomalies, and CNS dysfunction.

Practice questionsHigh-yield facts
ICD-10Q86.0 (fetal alcohol syndrome, dysmorphic)
Typical patientNewborn/child with history of prenatal alcohol exposure
Key findingSmooth philtrum, thin vermilion border, short palpebral fissures
First-line treatmentNo cure; early intervention, special education, supportive care
6 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

Fetal alcohol spectrum disorder (FASD) is an umbrella term for the range of physical, cognitive, behavioral, and neurodevelopmental abnormalities that result from prenatal exposure to alcohol. It includes several diagnostic categories:

  • Fetal alcohol syndrome (FAS) - full phenotype with growth deficits, facial dysmorphism, and CNS abnormalities
  • Partial FAS (pFAS) - some but not all features of FAS
  • Alcohol-related neurodevelopmental disorder (ARND) - CNS/behavioral effects without the full facial or growth phenotype
  • Alcohol-related birth defects (ARBD) - structural anomalies (cardiac, renal, skeletal) linked to prenatal alcohol exposure

FASD is considered the most common preventable cause of intellectual disability in the developed world. Estimated prevalence of the full spectrum is roughly 1-5% of school-age children in some US and European studies, though full FAS alone is less common (on the order of a few per 1,000 births). Rates vary significantly by population and maternal drinking patterns, and are likely underdiagnosed.

High-yield for exams
  • No safe amount or safe trimester of alcohol use has been established in pregnancy
  • Full FAS triad: growth deficiency + characteristic facial features + CNS dysfunction
  • Classic facial triad: smooth philtrum, thin vermilion border, short palpebral fissures
  • FASD is the leading preventable cause of intellectual disability in the developed world
  • ARND can have normal growth and face but significant cognitive/behavioral deficits
  • Diagnosis is clinical; no laboratory or imaging test confirms FASD
  • MRI may show corpus callosum hypoplasia/agenesis and cerebellar hypoplasia
  • Most common associated cardiac defect is a septal defect (ASD/VSD)

Etiology and risk factors

The cause is prenatal exposure to ethanol, which crosses the placenta freely and is directly toxic to the developing fetus, particularly the brain.

Risk factors and modifiers include:

  • Amount and pattern of drinking - binge drinking and heavy chronic use carry the highest risk, but no threshold has been proven safe
  • Timing - first-trimester exposure most strongly affects facial morphogenesis and organogenesis; exposure throughout pregnancy affects brain growth
  • Maternal factors - poor nutrition, smoking, advanced maternal age, lower socioeconomic status, and limited prenatal care increase severity
  • Genetic susceptibility - variation in maternal and fetal alcohol-metabolizing enzymes (ADH, ALDH) may modify risk

There is no known safe amount or safe time to drink alcohol during pregnancy, which is why major guidelines recommend complete abstinence.

Pathophysiology

Ethanol and its metabolite acetaldehyde cross the placenta and blood-brain barrier readily. Mechanisms of fetal injury include:

  • Direct neurotoxicity - increased neuronal apoptosis, impaired neuronal migration, and disrupted synaptogenesis, especially affecting the corpus callosum, cerebellum, hippocampus, and basal ganglia
  • Oxidative stress - alcohol metabolism generates reactive oxygen species that damage developing cells
  • Vascular disruption - alcohol causes vasoconstriction of placental and fetal vessels, impairing oxygen and nutrient delivery
  • Growth restriction - interference with insulin-like growth factor signaling contributes to intrauterine and postnatal growth deficiency
  • Craniofacial effects - alcohol disrupts migration of cranial neural crest cells during the critical period of facial development (roughly weeks 3-8), producing the characteristic facial phenotype

The net effect is a continuum of structural brain abnormality and functional neurodevelopmental impairment, which explains why severity and presentation vary widely even among children with similar exposure histories.

Clinical features

Full FAS requires findings in three domains; partial phenotypes may show only some.

Growth deficiency

  • Prenatal and/or postnatal growth restriction (height and/or weight at or below the 10th percentile)

Characteristic facial features

  • Smooth philtrum (reduced or absent vertical groove above the upper lip)
  • Thin vermilion border (thin upper lip)
  • Short palpebral fissures (small eye openings)
  • Other supportive features: flat midface, short nose, epicanthal folds, micrognathia

CNS abnormalities

  • Structural: microcephaly, reduced corpus callosum size, cerebellar hypoplasia
  • Functional: intellectual disability, poor executive function, attention deficits, impulsivity, impaired memory, poor social cognition, learning disabilities, motor coordination problems

Associated features

  • Behavioral problems (ADHD-like presentation, oppositional behavior)
  • Hearing and vision problems
  • Congenital heart defects (notably septal defects)
  • Renal anomalies and skeletal abnormalities (joint contractures, altered palmar creases)

Children with ARND may have normal growth and facial appearance but significant cognitive/behavioral deficits, making this subtype easy to miss.

Diagnosis

Diagnosis is clinical, based on history and physical findings; there is no confirmatory lab test or imaging study.

Key diagnostic elements

  • Confirmed or suspected history of prenatal alcohol exposure (maternal report, medical records; exposure may be unconfirmed in many cases)
  • Growth parameters plotted on standard growth charts
  • Facial measurement using the Lip-Philtrum Guide (standardized ranking of philtrum smoothness and lip thinness)
  • Palpebral fissure length measured against population norms
  • Neurodevelopmental and neuropsychological assessment (IQ testing, executive function, adaptive behavior)
  • Brain imaging (MRI) in selected cases to document structural abnormalities (e.g., corpus callosum agenesis/hypoplasia)

Diagnostic frameworks

Several systems exist (Institute of Medicine criteria, CDC/Hoyme criteria, Canadian and Australian guidelines); all require evaluation across the growth, facial, and neurobehavioral domains, with FAS requiring all three and other FASD categories requiring a subset. Diagnosis is ideally made by a multidisciplinary team (pediatrician, geneticist, psychologist, speech/occupational therapist).

Differential diagnosis

Several genetic and dysmorphic syndromes overlap with FAS and must be considered:

  • Williams syndrome - distinct facial gestalt, cardiovascular (supravalvular aortic stenosis), hypercalcemia, overly friendly personality
  • Noonan syndrome - webbed neck, pulmonic stenosis, short stature; distinct facial features
  • Cornelia de Lange syndrome - synophrys, long philtrum, limb anomalies
  • Dubowitz syndrome - microcephaly, growth deficiency, eczema
  • Toluene embryopathy - similar facial phenotype from maternal solvent abuse, important mimic
  • Idiopathic intellectual disability/autism spectrum disorder - when exposure history is absent or unclear, especially in ARND
  • Other prenatal teratogen exposures (e.g., anticonvulsants, maternal phenylketonuria)

A thorough maternal history and, where feasible, genetic testing help distinguish these from FASD when the exposure history is uncertain.

Management

There is no cure for FASD; management is supportive, multidisciplinary, and focused on maximizing function and preventing secondary disability.

Core principles

  • Early diagnosis and early intervention programs improve long-term outcomes
  • Individualized educational plans and special education support for learning disabilities
  • Behavioral therapy and parent training to address impulsivity, attention problems, and social skill deficits
  • Treatment of comorbid conditions (ADHD medications such as stimulants may help attention symptoms, though response can differ from typical ADHD)
  • Speech, occupational, and physical therapy as indicated
  • Management of associated congenital defects (cardiac, renal, skeletal) by relevant specialists
  • Stable, structured home environment; reduction of exposure to violence and further trauma, which are major modifiers of outcome
  • Family support, counseling, and connection to social services

Prevention

  • Universal screening for alcohol use in all pregnant women and women of reproductive age
  • Clear counseling that no amount of alcohol is known to be safe during pregnancy (consistent WHO, CDC, ACOG, and major European society guidance)
  • Early referral to addiction services for women with alcohol use disorder who are pregnant or planning pregnancy

Management is lifelong in many cases, given that cognitive and behavioral deficits typically persist into adulthood.

Complications and prognosis

FASD causes lifelong impairment in most affected individuals, though severity varies widely.

  • Cognitive/academic: persistent intellectual disability or learning disabilities, poor executive function
  • Mental health: high rates of ADHD, anxiety, depression, and other psychiatric comorbidities
  • Social/behavioral: difficulty with social judgment, increased risk of substance use disorder, trouble with the law, unemployment, and dependent living as adults
  • Medical: persistent effects of any associated congenital heart, renal, or skeletal anomalies; vision and hearing problems

Facial features often become less distinct with age, which can make diagnosis in adolescence and adulthood more difficult. Early diagnosis, a stable and nurturing environment, and consistent intervention services are the strongest predictors of better long-term outcomes.

Mnemonic

FAS facial triad - "SST": Smooth philtrum, Short palpebral fissures, Thin upper lip.

Practice questions

1. A 6-year-old boy is brought in for evaluation of poor school performance. He has a history of confirmed heavy maternal alcohol use throughout pregnancy. On exam, he has a smooth philtrum, thin upper lip, short palpebral fissures, and height/weight at the 5th percentile. Neuropsychological testing shows impaired executive function and below-average IQ. Which of the following is the most likely diagnosis?

Answer: B. This child has all three required domains for full FAS: growth deficiency (height/weight at 5th percentile), the characteristic facial triad (smooth philtrum, thin vermilion border, short palpebral fissures), and CNS dysfunction (impaired executive function, low IQ). ARND would apply if facial and growth findings were absent. The other syndromes have distinct, non-alcohol-related facial and systemic features.

2. A researcher is studying the embryologic basis of the facial abnormalities seen in fetal alcohol syndrome. These facial changes are primarily due to disruption of which developmental process, and during which approximate gestational window?

Answer: B. The characteristic facial phenotype of FAS results from alcohol-induced disruption of cranial neural crest cell migration during the critical period of facial morphogenesis, roughly weeks 3-8 of gestation. This timing explains why first-trimester exposure has the strongest impact on facial dysmorphism, while exposure throughout pregnancy affects brain growth and function.

3. A pediatrician is counseling a woman who is 8 weeks pregnant and reports drinking one to two glasses of wine per week since conception. She asks whether this amount of alcohol is safe for the fetus. What is the most appropriate response?

Answer: C. Major guideline bodies (WHO, CDC, ACOG, and European societies) consistently state that no amount or type of alcohol has been established as safe at any point in pregnancy. The correct counseling response is complete abstinence from alcohol, not reassurance about small amounts or a false sense of safety based on drink type or trimester.

Frequently asked questions

What causes fetal alcohol spectrum disorder?

FASD is caused by alcohol exposure during pregnancy, which crosses the placenta and directly damages the developing fetal brain and other organs. Risk and severity depend on the amount, pattern, and timing of drinking, with binge and heavy chronic use carrying the greatest risk. No amount of alcohol has been proven safe at any point in pregnancy.

What are the first signs of FASD in a newborn?

The earliest signs are often growth restriction and characteristic facial features present at birth, including a smooth philtrum, thin upper lip, and small eye openings. Some infants also show irritability, feeding difficulties, or tremulousness related to withdrawal. Milder forms (ARND) may show no visible signs until developmental or behavioral problems emerge later in childhood.

How is FASD diagnosed?

FASD is diagnosed clinically using a combination of confirmed or suspected prenatal alcohol exposure, growth measurements, standardized facial feature assessment, and neurodevelopmental testing. There is no blood test or imaging study that confirms the diagnosis on its own, though brain MRI can support findings. Diagnosis is best made by a multidisciplinary team familiar with FASD criteria.

Is fetal alcohol spectrum disorder curable?

No, FASD is not curable because the brain and physical changes from prenatal alcohol exposure are permanent. Management focuses on early intervention, special education, behavioral therapy, and treating associated medical problems to improve function and quality of life. Outcomes are generally better with early diagnosis and a stable, supportive environment.

FAS vs ARND - what is the difference?

Fetal alcohol syndrome (FAS) includes the full triad of growth deficiency, characteristic facial features, and CNS dysfunction, while alcohol-related neurodevelopmental disorder (ARND) involves CNS and behavioral effects of prenatal alcohol exposure without the typical facial or growth changes. Both result from the same underlying cause and exist on the same spectrum, but ARND is often harder to recognize and diagnose.

Key drugs

methylphenidateamphetamine saltsatomoxetine
Williams syndromeNoonan syndromeCornelia de Lange syndromeDubowitz syndromeToluene embryopathyAttention-deficit/hyperactivity disorderIntellectual disabilityNeonatal abstinence syndrome

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: Q86.0

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.